Citation Hong Kong Practitioner, 1996, v. 18 n. 2, p

Similar documents
Consensus Guideline on Accelerated Partial Breast Irradiation

Citation Hong Kong Practitioner, 1997, v. 19 n. 5, p

Surgery for Breast Cancer

Recurrence following Treatment of Ductal Carcinoma in Situ with Skin-Sparing Mastectomy and Immediate Breast Reconstruction

Breast Surgery When Less is More and More is Less. E MacIntosh, MD June 6, 2015

METASTASES OF PATIENTS WITH EARLY STAGES OF BREAST CANCER

Treatment Results and Prognostic Factors of Early Breast Cancer Treated with a Breast Conserving Operation and Radiotherapy

The New England Journal of Medicine

Debate Axillary dissection - con. Prof. Dr. Rodica Anghel Institute of Oncology Bucharest

BREAST CANCER SURGERY. Dr. John H. Donohue

CONSERVATIVE therapy in the management of

Outcomes of patients with inflammatory breast cancer treated by breast-conserving surgery

Surgical Therapy: Sentinel Node Biopsy and Breast Conservation

ANNEX 1 OBJECTIVES. At the completion of the training period, the fellow should be able to:

Conservative Surgery and Radiation Stage I and II Breast Cancer

Breast cancer: an update

By Rufus Mark, MD, Gail Lebovic, MD, Valerie Gorman, MD, Oscar Calvo, PhD. TABLE 1 EARLY STAGE BREAST CANCER RANDOMIZED TRIALS M vs.

Breast Cancer. Most common cancer among women in the US. 2nd leading cause of death in women. Mortality rates though have declined

Resection Margins in Breast Conserving Surgery. Alberto Costa, MD Canton Ticino Breast Unit Lugano, Switzerland

Breast Cancer. Saima Saeed MD

Surgical Considerations in Breast Cancer treated with Neoadjuvant Therapy

Sentinel Lymph Node Biopsy for Breast Cancer

How can surgeons help the Radiation Oncologists?

1 Department of Radiation Oncology 2 Department of Surgery 3 Department of Pathology and Laboratory Medicine

Breast Cancer Diagnosis, Treatment and Follow-up

Acute and late adverse effects of breast cancer radiation: Two hypo-fractionation protocols

Invasive Papillary Breast Carcinoma

Oncoplastic breast surgery in a Danish perspective II: Reconstructive strategy in oncoplastic breast surgery

Breast Cancer? Breast cancer is the most common. What s New in. Janet s Case

Ductal Carcinoma-in-Situ: New Concepts and Controversies

Implications of ACOSOG Z11 for Clinical Practice: Surgical Perspective

Radiotherapy Physics and Equipment

Breast Surgery: Yesterday, Today and Tomorrow

ORIGINAL ARTICLE. Breast Conservation Surgery Using Nipple-Areolar Resection for Central Breast Cancers

Table of contents. Page 2 of 40

ARROCase - April 2017

Advances in Breast Surgery. Catherine Campo, D.O. Breast Surgeon Meridian Health System April 17, 2015

Advances in Localized Breast Cancer

Clinical Trials of Proton Therapy for Breast Cancer. Andrew L. Chang, MD 張維安 Study Chair

Why Do Axillary Dissection? Nodal Treatment and Survival NSABP B04. Revisiting Axillary Dissection for SN Positive Patients

Loco-Regional Management After Neoadjuvant Chemotherapy

Guidelines for the treatment of Breast cancer with radiotherapy v.1.0 September 2017

Page 1. AHN-JHU Breast Cancer Symposium. Novel Local Regional Clinical Trials. Background. Neoadjuvant Chemotherapy Benefit.

Implications of ACOSOG Z11 for Clinical Practice: Surgical Perspective

Loco-Regional Management After Neoadjuvant Chemotherapy

SIGN. Management of breast cancer in women. December Scottish Intercollegiate Guidelines Network. A national clinical guideline

ACRIN 6666 Therapeutic Surgery Form

Subcutaneous mastectomy for primary breast cancer and ductal carcinoma in situ

SSO-ASTRO Consensus Guidance Margins for Breast-Conserving Surgery with Whole Breast Irradiation in Stage I and II Invasive Breast Cancer

BREAST MRI. Elizabeth A. Rafferty, M.D. Avon Comprehensive Breast Center Massachusetts General Hospital Harvard Medical School

Research Article Risk Factors of the Invasive Breast Cancer Locoregional Recurrence

NEW PERSPECTIVES OF INTRAOPERATIVE US GUIDANCE

Paget's Disease of the Breast: Clinical Analysis of 45 Patients

Recent Update in Surgery for the Management of Breast Cancer

Results of the ACOSOG Z0011 Trial

Breast Cancer Treatment

Radiation and DCIS. The 16 th Annual Conference on A Multidisciplinary Approach to Comprehensive Breast Care and Imaging

What is an Adequate Lumpectomy Margin in 2018?

Position Statement on Management of the Axilla in Patients with Invasive Breast Cancer

BREAST MRI. Elizabeth A. Rafferty, M.D. Avon Comprehensive Breast Center Massachusetts General Hospital Harvard Medical School

Cryoablation in the Management of Early Stage Breast Cancer

Sentinel Node Biopsy. Is There Any Role for Axillary Dissection? JCCNB Nov 20, Stephen B. Edge, MD

16/09/2015. ACOSOG Z011 changing practice. Presentation outline. Nodal mets #1 prognostic tool. Less surgery no change in oncologic outcomes

Protocol of Radiotherapy for Breast Cancer

Koebner Phenomenon in Radiation Associated Angiosarcoma of the Breast: Linear Metastasis in Split Skin Graft Donor Site

Classifying Local Disease Recurrences after Breast Conservation Therapy Based on Location and Histology

The Surgical Management of Primary Invasive Breast Cancer

RUTGERS CANCER INSTITUTE OF NEW JERSEY - ROBERT WOOD JOHNSON MEDICAL SCHOOL INTERDISCIPLINARY BREAST SURGERY FELLOWSHIP CORE EDUCATIONAL OBJECTIVES

Intraoperative. Radiotherapy

Contributo della medicina nucleare nei tumori mammari: dal linfonodo sentinella alla IART

New Technologies in Radiation Oncology. Catherine Park, MD, MPH Advocate Good Shepherd Hospital

Management of Ductal Carcinoma in Situ of the Breast: A Clinical Practice Guideline

When do you need PET/CT or MRI in early breast cancer?

What is Cancer? Petra Ketterl, MD Medical Oncology and Functional Medicine

Treatment results and predictors of local recurrences after breast conserving therapy in early breast carcinoma

EARLY STAGE BREAST CANCER AND THE EMERGING ROLE OF IORT

It is a malignancy originating from breast tissue

Case Conference: Post-Mastectomy Radiotherapy

Case Scenario 1. 2/15/2011 The patient received IMRT 45 Gy at 1.8 Gy per fraction for 25 fractions.

RADIOTHERAPY IN BREAST CANCER :

Breast Cancer. Dr. Andres Wiernik 2017

Repeating Conservative Surgery after Ipsilateral Breast Tumor Reappearance: Criteria for Selecting the Best Candidates

Radiation Therapy for the Oncologist in Breast Cancer

Differences in outcome for positive margins in a large cohort of breast cancer patients treated with breast-conserving therapy

PRACTICE GUIDELINE FOR BREAST CONSERVATION THERAPY IN THE MANAGEMENT OF INVASIVE BREAST CARCINOMA

Certified Breast Care Nurse (CBCN ) Test Content Outline (Effective 2018)

BREAST CONSERVATION TREATMENT IN EARLY STAGE DISEASE AND DCIS LAWRENCE J. SOLIN, MD, FACR, FASTRO

equally be selected on the basis of RE status of the primary tumour. These initial studies measured RE

Radiation Treatment for Breast. Cancer. Melissa James Radiation Oncologist August 2015

Hypofractionated radiotherapy for breast cancer: too fast or too much?

Updates on management of the axilla in breast cancer the surgical point of view

A712(18)- Test slide, Breast cancer tissues with corresponding normal tissues

Radiotherapy Management of Breast Cancer Treated with Neoadjuvant Chemotherapy. Julia White MD Professor, Radiation Oncology

Breast cancer reconstruction surgery (immediate and delayed) across Ontario: Patient indications and appropriate surgical options

Special Paper. Ten Year Results of a Randomised Trial Comparing Two Conservative Treatment Strategies for Small Size Breast Cancer

Recurrence, new primary and bilateral breast cancer. José Palacios Calvo Servicio de Anatomía Patológica

03/14/2019. Postmastectomy radiotherapy; the meta-analyses, and the paradigm change to altered fractionation Mark Trombetta M.D.

PMRT for N1 breast cancer :CONS. Won Park, M.D., Ph.D Department of Radiation Oncology Samsung Medical Center

How to Use MRI Following Neoadjuvant Chemotherapy (NAC) in Locally Advanced Breast Cancer

Seventh Edition Staging 2017 Breast

Transcription:

Title Conservative surgery for breast cancer Author(s) Poon, RTP; Chow, LWC; Au, GKH Citation Hong Kong Practitioner, 1996, v. 18 n. 2, p. 68-72 Issued Date 1996 URL http://hdl.handle.net/722/45367 Rights This work is licensed under a Creative Commons Attribution- NonCommercial-NoDerivatives 4.0 International License.

UPDATE ARTICLE Conservative For Breast Cancer Ronnie T.P. Poon*, FRCS(Edin) Medical Officer Louis W.C. Chow, FRCS(Glas), FHKAM() Lecturer Gordon K.H. Au, FRCR, FHKAM(Radiology) Consultant Department of and Radiotherapy Queen Mary Hospital Abstract Modified radical mastectomy has been the traditional surgical treatment of early breast cancer but in recent years breast conserving surgery has been used with no significant difference in local recurrence and survival rates. This article describes the principle of breast conservation therapy, reviews the outcome of trials of breast conservation therapy and discusses the criteria for selecting patients with early breast cancer for breast conservation therapy. The results of 64 breast conserving surgery performed in Queen Mary Hospital from 1986-1994 are presented. Ten patients (16%) developed local recurrence and seven of them had salvage mastectomy. The five year survival rate was 85%, comparable to Western series. Keywords: Introduction Breast cancer, breast conservation surgery The incidence of breast cancer in Hong Kong has increased by 30% since 1981.' It is the second leading cause of death among women in Hong Kong. remains the only hope of cure for early operable breast cancer. Operable breast cancer can be defined as a mobile tumour in the breast with or without mobile axillary lymph nodes in the absence of obvious distant metastasis. The main objective of surgery is to eradicate local disease and prevent loco-regional recurrence. Up to early 1980s, surgical treatment of breast cancer almost always involved total removal of the breast, in the form of either radical mastectomy or more popularly modified radical mastectomy. However, mastectomy results in loss of body image and psychological trauma in many patients. Studies have documented high levels of anxiety, depression and sexual dysfunction among those who have had mastectomy, sometimes severe enough to require psychiatric intervention. 2 ' 3 This has led to the increasing use of breast conserving surgery in the last decade. Principle of Conservation Therapy for Breast Cancer Different techniques and terms have been used for conservative breast surgery. The terms ' lumpectomy', 'tumourectomy', and 'tylectomy' imply removal of the tumour mass with a minimal margin of normal breast tissue around it. Wide local excision or segmental mastectomy implies excision of the tumour with at least 1cm tumour free margin. Because of the propensity for ductal carcinoma to spread towards the nipple along the ducts, Veronesi et al used a more aggressive approach of excision of a breast quadrant (quandrantectomy) which included excision of the overlying skin and underlying pectoralis major fascia. 4 This more extensive resection theoretically reduces local recurrence but at the expense of more cosmetic deformity. * Address for correspondence: Dr. Ronnie T.P. Poon, Department of, Queen Mary Hospital, Hong Kong. 68

Hong Kong Practitioner 18 (2) February 1996 After local excision of the tumour, radiotherapy should be given to the remaining breast tissue, first to eradicate any residual microscopic disease at the site of primary tumour, and second, to treat other possible foci of invasive or in-situ cancer elsewhere in the remaining breast tissue. This has been shown to reduce the risk of local recurrence after conservative surgery. 5 Two prospective studies with short follow-up suggest that breast irradiation can be safely omitted in patients with small (<2cm) completely excised unifocal tumours found on mammogram. 6 " 7 However, until further studies have clarified the need of irradiation in small completely excised tumours, the current recommendation is that all patients should have post-operative radiotherapy after conservative surgery for breast cancer. About 50% of patients with symptomatic operable breast cancer have axillary lymph node metastasis at the time of presentation but clinical assessment of axillary node involvement is notoriously unreliable with an overall error rate of approximately 30%. 8 The management of the axilla in early breast cancer is controversial. 8 Axillary dissection gives excellent local tumour control but axillary irradiation has been shown to be as effective, with long term recurrence rate of less than 2%.'' However, axillary irradiation can result in an uncommon but serious complication of radiationinduced brachial plexus neuropathy. Another drawback of axillary irradiation is that it does not give information on prognosis nor identify the group of patients with positive lymph nodes who will benefit most from systemic adjuvant therapy. Axillary lymph node sampling instead of dissection reduces complication rate but is often inaccurate. '" We consider wide local excision, plus axillary dissection and post-operative breast irradiation as the best form of breast conservation therapy. Outcome of Breast Conservation vs Mastectomy Hayward and his colleagues reported the first randomized trial to compare radical mastectomy and wide local excision plus both breast and nodal irradiation in 1977. l2 In their trial conservative surgery resulted in increased local recurrence and decreased survival compared to radical treatment, but the dose and technique of radiotherapy used to treat the breast and axilla after local excision are now known to be inadequate. Five more recent large randomized prospective trials have shown no significant difference in local recurrence and survival in comparison between breast conservation surgery with mastectomy. 4 " 5 ' 13 " 15 Table 1 shows the results of these randomized trials. Table 1 : Randomized Trials of Conservative Breast Therapy for Breast Cancer Trial Treatment arms No. of patients Follow up (yr) Local relapse (%) Survival (%) Hayward et al 1977 Veronesi et al 1990 Fisher et al 1989 Sarrazin et al 1989 Litcher et al 1992 Blichert et al 1988 RM + RT LE + RT RM QUART LE + AD I.E + AD + RT 130 122 349 352 590 630 629 91 88 116 121 306 321 13 8 5 2 8 30 O jl 3 ' 8 16 6 6 17 4 2 68 58 69 76 80 79 85 89 76 80 RM = radical mastectomy, = modified radical mastectomy, RT = radiotherapy, LE = local excision, AD = axillary dissection, QUART = quadrantectomy, axillary dissection, and breast irradiation. 69 (Continued on page )

Hong Kong Practitioner 18 (2) February 1996 Local Recurrence after Breast Conservation The overall recurrence rate after breast conservation surgery is 3-6% although some series reported higher figures (Table 1). Local recurrence may be treated with salvage mastectomy and further conservative surgery is sometimes possible in small localized recurrence. However, ipsilateral breast tumour recurrence is a marker of risk of developing distant metastasis though it is not the cause of the metastasis. 16 incision for the axillary lymph node dissection, as shown in Figure 1. Figure 1 : Cosmetic Result after Wide Local Excision and Axillary Dissection The identification of factors associated with breast recurrence after conservation surgery is important to help selecting appropriate patients for conservative surgery. The most important factors that predict increased risk of breast recurrence are: 7 * Positive surgical margin * Extensive DCIS (ductal carcinoma in-situ) * Multiple tumours» High nuclear grade of tumour The size of tumour, tumour histological type and nodal status are not consistently associated with increased risk of local recurrence. 18 Cosmetic Result after Breast Conservation An important goal of conservative breast surgery is a good cosmetic outcome after surgery and radiotherapy. The cosmetic result is affected by the extent and technique of local surgery and radiotherapy. Factors related to the operation that adversely affect cosmesis include large resection (especially in a small breast), large radial incision, same incision for breast resection and axillary dissection and re-excision of tumour bed, while factors related to radiotherapy include number of radiation fields and radiation boost dose. 19 The best cosmetic result is obtained with a circumferential incision for the lumpectomy and a separate axillary Patient Selection for Breast Conservation The important criteria for patient selection for breast conservation surgery are the feasibility of removing the primary tumour without causing serious cosmetic deformity or unacceptable risk of tumour recurrence. The size of the primary tumour is an important factor and tumours larger than 4cm are considered not suitable for breast conservation but the size of the tumour must be related to the size of the breast in the judgment. Central tumours are relative contraindication as such tumours are often diffuse and difficult to resect without major cosmetic deformity and many women will prefer mastectomy if the nipple has to be excised. Extensive DCIS and multifocal disease on mammogram are highly predictive of local recurrence and conservative surgery is contraindicated. Hence it is important to obtain mammography before consideration of surgical options. Breast conservation surgery is also inappropriate in male patients and pregnant patients. Patient's preference is important as some patients may prefer mastectomy to avoid the need of postoperative breast irradiation while some may feel more secure after mastectomy. Figure 2 summaries the surgical management protocol for patients presenting with operable breast cancer in our centre.

Conservative for Breast Cancer Figure 2: Management of Early Breast Cancer Early breast cancer 4, Confirm diagnosis: - FNA / biopsy - Mammogram 4 Counsel patient of improved cosmesis and hopefully a reduction in psychological trauma. The majority of early operable breast cancer patients are suitable candidates and with the earlier detection of breast cancer by screening, more patients may benefit from conservative surgery. There is a group of patients who should have mastectomy instead of conservative surgery, and reconstruction may be offered as an alternative to improve cosmesis. - Tumour < 4cm - Not extensive DCIS or multifocal disease - Not central tumour - Patient request Breast Conservation DCIS = Ductal Carcinoma In-Situ Local Experience Tumour > 4cm Extensive DCIS or multifocal disease Central tumour Pregnant patient Male Recurrence after conservative surgery Patient request Modified Radical Mastectomy ± Reconstruction From 1986-1994 64 female patients underwent wide local excision and axillary dissection followed by breast irradiation in Queen Mary Hospital. The median age at diagnosis was 51 (range 24-81) years and 50% of patients were post-menopausal. The median tumour size was 2.5cm and 20% had axillary lymph node involvement. Ten (16%) patients developed recurrence in the ipsilateral breast and seven underwent salvage mastectomy. Five (8%) eventually died. The 5-year survival was 85%. The result was comparable to Western series. Conclusion Breast conservation therapy is an established treatment option for early breast cancer. It produces similar survival rate when compared with radical or modified radical mastectomy, but it has the advantage References 1. Cheung PSY. Breast cancer in Hong Kong- the need for early detection JHK Med Assoc 1992; 44: 298-252. 2. McGuire WL, Clark GM. Prognostic factors and treatment decisions in axillary node-negative breast cancer patients. N Eng F Med 1992; 326: 1756-1761. 3. Morris T, Greer HS, White P. Psychological and social adjustment to mastectomy: a two year follow-up study. Cancer 1977; 40:2381-2387 4. Veronesi U, Banfi A, Salvador! B et al. Breast conservation is the treatment of choice in small breast cancer; long term results of a randomized trial. Eur J Cancer 1990; 26:668-670. 5. Fisher B, Redmond C, Poisson R el al. Eight year results of a randomized trial comparing a conservative treatment to mastectomy in early breast cancer. N Eng J Med 1989; 320; 822-828. 6. The Uppsala-Orebro Breast Cancer Study Group. Sector resection with or without post-operative radiotherapy for stage breast cancer: a randomized trial. J Nat Cancer Inst 1990; 82: 277-282. 7. Clark RM, McCulloch PB, Levine MN etal. A randomized clinical trial to assess the effectiveness of breast irradiation following lumpectomy and axillary dissection for node negative breast cancer. J Nat Cancer Inst 1992, 84: 683-689. 8- Sacks NPM, Barr LC, Allan SM at al. The role of axillary dissection in operable breast cancer. Breast 1992; 1:41-49. 9. Mazeron JJ, Otmezguine Y, Huart J et al. Conservative treatment of breast cancer: results of management of axillary lymph node in 3353 patients. Lancet 1985; 1(8442): 1387.. Locker AP, Ellis, Morgan DAL, et al. Factors influencing local recurrence after excision and radiotherapy for primary breast cancer. Br J Surg 1989; 76; 890-894. 11. Davier GC, Millis RR, Hayward JL. Assessment of axillary node status. Ann Surg 1980; 192; 148-151. 12. Hayward JL. The Guy's trial of treatment of early breast cancer. World J Surg 1977; 1: 314-316. 13. Sarrazin D, LeMG, ArriagadaR et a/. Ten-year results of a randomized trial comparing a conservative treatment to mastectomy in early breast cancer. Radiother Oncol 1989; 14: 177-184. 14. Litchter AS, Lippman ME, Danforth DN el al. Mastectomy vs breastconserving therapy in the treatment of stage 1 and 2 cancer of the breast: a randomized trial at the National Cancer Institute. J Clin Oncol 1992; JO; 976-983. 15. Blichert-Toft M, Brincker M, Anderson JA et al. A Danish randomized trial comparing breast-preserving therapy with mastectomy in mammary carcinoma. Acta Oncol 1988; 27: 621-677. 16. Fisher B, Anderson S, Fisher ER et al. Significance of ipsilateral breast tumour recurrence after lumpectomy. Lancet 1991; 338:327-331. 17. S totter A, Atkinson EN, Fairstone BA et al. Survival following locoregional recurrence after breast conservation therapy for cancer. Ann Surg 1990; 212(2): 166-172. 18. Kurtz JM. Factor influencing the risk of local recurrence in the breast. Eur J Cancer 1992; 28: 660-666. 19. HafftyBG, Goldberg NB, Fisher D et al. Conservative surgery and radiation therapy in breast carcinoma: local recurrence and prognostic implications. Int J Radiat Oncol Biol Phy 1989; 17: 727-732. 72